Asklepion Pharmaceuticals H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Baltimore, MD HQ🌐 asklepionpharm.com
Does Asklepion Pharmaceuticals sponsor H-1B visas?
Yes. Asklepion Pharmaceuticals has filed 6 H-1B LCAs with the U.S. Department of Labor between FY2017 and FY2026. In FY2026 Asklepion Pharmaceuticals filed 1 H-1B LCA. No PERM green-card cases are on record.
It files most often for Managing Director/COO roles, most in Baltimore, MD.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 1 | $500k |
| FY2024 | 1 | $400k |
| FY2022 | 1 | $400k |
| FY2020 | 1 | $400k |
| FY2018 | 1 | $400k |
| FY2017 | 1 | $250k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds aren’t available.
Patents
- Granted
- 2
- US patents
- Published, not yet granted
- 5
- applications
- Most recent grant
- March 4, 2025
- Top area
- Preparations for medical1
About Asklepion Pharmaceuticals
Asklepion Pharmaceuticals is a pharma & biotech company based in Baltimore, MD. It was founded in 2006.
- Name (DOL filings)
- Asklepion Pharmaceuticals, LLC
- Listed
- Private
- Sponsoring since
- FY2017 or earlier
- Headquarters
- Baltimore, United States
- Industry
- Pharma & biotech
- Founded
- 2006
- H-1B filings
- 6
- Median base
- $400,000
- Website
- asklepionpharm.com
H-1B sponsors similar to Asklepion Pharmaceuticals
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Antares Pharma | 8 | 3 | $140k | 0 | — |
| Avidity Biosciences | 8 | 4 | $125k | 1 | — |
| Cellbae | 8 | 4 | $78k | 1 | — |
| Asklepion Pharmaceuticals | 6 | 1 | $500k | 0 | — |
| Bioalgo | 6 | 1 | $113k | 0 | — |
| Connect Biopharm | 6 | 2 | $140k | 0 | — |
| Dren Bio | 6 | 3 | $144k | 2 | — |
